{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:53:00Z","timestamp":1793418780240,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jacc.2020.03.060","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T16:14:49Z","timestamp":1589818489000},"page":"2602-2618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":334,"title":["Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women"],"prefix":"10.1016","volume":"75","author":[{"given":"Leslie","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Epps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"Minissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Vaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle Santos","family":"Volgman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.03.060_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics -2019 update; a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20142011 update: a guideline from the American Heart Association","volume":"57","author":"Mosca","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib3","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib4","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.117.031403","article-title":"Association of spontaneous preterm delivery and future maternal cardiovascular disease","volume":"137","author":"Minissian","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2020.03.060_bib9","article-title":"Association of adverse pregnancy outcomes with hypertension 2 to 7 years postpartum","volume":"8","author":"Haas","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.03.060_bib10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jacc.2018.12.092","article-title":"Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC Review topic of the week","volume":"73","author":"Lane-Cordova","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib11","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/AOG.0000000000003243","article-title":"ACOG practice bulletin no. 212: pregnancy and heart disease","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.03.060_bib12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.117.09246","article-title":"All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease","volume":"70","author":"Tooher","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2020.03.060_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/HJH.0000000000000855","article-title":"Hypertensive disorders first identified in pregnancy increase risk for incident prehypertension and hypertension in the year after delivery","volume":"34","author":"Black","year":"2016","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2020.03.060_bib14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/heartjnl-2017-312299","article-title":"Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy","volume":"104","author":"Jarvie","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.060_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M17-2740","article-title":"Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development","volume":"169","author":"Stuart","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","article-title":"Long-term cardiovascular risk in women with hypertension during pregnancy","volume":"74","author":"Honigberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib17","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion no. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.03.060_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002488","article-title":"Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study","volume":"15","author":"Daly","year":"2018","journal-title":"PLOS Medicine"},{"key":"10.1016\/j.jacc.2020.03.060_bib19","article-title":"Preterm delivery and future risk of maternal cardiovascular disease: a systematic review and meta-analysis","volume":"7","author":"Wu","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.03.060_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.116.025954","article-title":"Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women: clinical perspective","volume":"135","author":"Tanz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1161\/CIRCULATIONAHA.112.000285","article-title":"Pregnancy loss and later risk of atherosclerotic disease","volume":"127","author":"Ranthe","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/heartjnl-2012-303237","article-title":"Miscarriages and future maternal CVD: a systematic review and meta-analysis","volume":"99","author":"Oliver-Williams","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.060_bib23","article-title":"ACOG practice bulletin no. 204: fetal growth restriction","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.03.060_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10641950601146574","article-title":"Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction","volume":"26","author":"Manten","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.jacc.2020.03.060_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.112.194159","article-title":"Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction","volume":"60","author":"Melchiorre","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2020.03.060_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.03.060_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pd.5645","article-title":"Aspirin for prevention of preeclampsia and fetal growth restriction","volume":"40","author":"Loussert","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jacc.2020.03.060_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurheartj\/ehy863","article-title":"Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway","volume":"40","author":"Markovitz","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib29","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jacc.2018.05.077","article-title":"Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction","volume":"72","author":"Stuart","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2020.03.060_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697130601114917","article-title":"Menopause and cardiovascular disease: the evidence","volume":"10","author":"Rosano","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.jacc.2020.03.060_bib31","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"11","author":"Zhu","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2020.03.060_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.03.060_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2020.03.060_bib34","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","author":"Osibogun","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib35","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2020.03.060_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.10.059","article-title":"Endothelial\u00a0dysfunction in PCOS: role of obesity and adipose hormones","volume":"119","author":"Carmina","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","article-title":"Ethnic differences in the phenotypic expression of polycystic ovary syndrome","volume":"78","author":"Zhao","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jacc.2020.03.060_bib38","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jacc.2020.03.060_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"Teede","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2020.03.060_bib40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004","volume":"65","author":"Feldman","year":"2013","journal-title":"Art and Rheum"},{"key":"10.1016\/j.jacc.2020.03.060_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/eci.10.98","article-title":"Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention","volume":"7","author":"McMahon","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jacc.2020.03.060_bib43","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.03.060_bib44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/annrheumdis-2014-206411","article-title":"The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease","volume":"75","author":"Myasoedova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.03.060_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.03.060_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib48","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib49","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib50","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jacc.2018.02.033","article-title":"Hypertension across a woman's life cycle","volume":"71","author":"Wenger","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2009.1060","article-title":"Diet and lifestyle risk factors associated with incident hypertension in women","volume":"302","author":"Forman","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.03.060_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib53","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.83.s2.06","article-title":"Fibromuscular dysplasia: advances in understanding and management","volume":"83","author":"Brinza","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccl.2012.04.005","article-title":"Hypertension in pregnancy","volume":"30","author":"Vest","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacc.2020.03.060_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamacardio.2019.5306","article-title":"Sex differences in blood pressure trajectories over the life course","volume":"5","author":"Ji","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib56","article-title":"Wenger NK Adverse cardiovascular outcomes for women\u2014biology, bias, or both?","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib57","first-page":"e157","article-title":"Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women","volume":"25","author":"Routledge","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/HYPERTENSIONAHA.110.156828","article-title":"Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women","volume":"57","author":"Boggia","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2020.03.060_bib59","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib60","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/HJH.0000000000001619","article-title":"Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial","volume":"36","author":"Foy","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2020.03.060_bib61","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.amjcard.2018.05.046","article-title":"Sex differences of patients with systemic hypertension (from the Analysis of the Systolic Blood Pressure Intervention Trial [SPRINT])","volume":"122","author":"Ochoa-Jimenez","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib62","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.amjmed.2016.06.022","article-title":"Women, hypertension, and the systolic blood pressure intervention trial","volume":"129","author":"Wenger","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib63","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/eurheartj\/ehn427","article-title":"Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials","volume":"29","author":"Turnbull","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib64","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.107.105296","article-title":"Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study","volume":"51","author":"Os","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2020.03.060_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamainternmed.2016.6821","article-title":"Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial","volume":"177","author":"Puttnam","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib66","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00125-019-4939-5","article-title":"Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course","volume":"62","author":"Huebschmann","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2020.03.060_bib67","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risk: Findings from the Swedish National Diabetes Registry","volume":"139","author":"Sattar","year":"2019","journal-title":"Circ"},{"key":"10.1016\/j.jacc.2020.03.060_bib68","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohort, including 775, 385 individuals and 12,539 strokes","volume":"383","author":"Peters","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.03.060_bib69","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2213-8587(18)30079-2","article-title":"Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980,793 adults from 68 prospective studies","volume":"6","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2020.03.060_bib70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12916-019-1355-0","article-title":"Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants","volume":"17","author":"Wang","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwx324","article-title":"Sex differences in the associations of diabetes with cardiovascular disease outcomes among African-American and white participants in the Atherosclerosis Risk In Communities Study","volume":"187","author":"George","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib72","first-page":"203","article-title":"Sex differences in the association of risk factors for heart failure incidence and mortality","volume":"106","author":"Sillars","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.060_bib73","first-page":"123","article-title":"Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience","volume":"6","author":"Anichini","year":"2013","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jacc.2020.03.060_bib74","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/dc18-0344","article-title":"MASTERMIND Consortium Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial data","volume":"41","author":"Dennis","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2020.03.060_bib75","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A\u00a0clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib76","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s00125-018-4630-2","article-title":"Empagliflozin in women with type 2 diabetes and cardiovascular disease\u2014an analysis of EMPA-REG OUTCOME","volume":"61","author":"Zinman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2020.03.060_bib77","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/CIRCULATIONAHA.118.035550","article-title":"Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatments, and control in the United States, 2001-2016","volume":"139","author":"Peters","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib78","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/CIRCULATIONAHA.118.039100","article-title":"Cardiovascular risk and risk factor management in type 2 diabetes:a population-based cohort study assessing sex disparities","volume":"139","author":"Wright","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib79","first-page":"S55","article-title":"Glycemic targets: standards of medical care in diabetes\u20132018","volume":"41 Suppl 1","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2020.03.060_bib80","article-title":"Cardiovascular disease and risk management: standards of medical care in diabetes\u20132018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2020.03.060_bib81","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guideline on diabetes, pre-diabetes, and cardiovascular disease developed in collaboration with the EASD: The Task Force for Diabetes, Pre-Diabetes, and Cardiovascular Disease of the ESC and EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib82","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2020.03.060_bib83","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1751-7141.2009.00059.x","article-title":"Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis","volume":"13","author":"Bukkapatnam","year":"2010","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib84","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2011.09.067","article-title":"Meta-analysis of statin effects in women versus men","volume":"59","author":"Kostis","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib85","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.03.060_bib86","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis Society Consensus Panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"Suppl 7","key":"10.1016\/j.jacc.2020.03.060_bib87","first-page":"S35","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016)","volume":"32","author":"Mancini","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2013.06.004","article-title":"Treatment strategies in patients with statin intolerance: The Cleveland Clinic Experience","volume":"166","author":"Mampuya","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.03.060_bib90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleotrophic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmcol Toxicol"},{"key":"10.1016\/j.jacc.2020.03.060_bib91","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib92","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib93","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib94","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamacardio.2017.0747","article-title":"Long-term low-density lipoprotein cholesterol\u2013lowering efficacy, persistence, and safety of evolocumab in treatment of hypercholesterolemia","volume":"2","author":"Koren","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib95","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2020.03.060_bib96","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A\u00a0randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib97","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/heartjnl-2014-306342","article-title":"Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women","volume":"101","author":"Van Kruijsdijk","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.060_bib98","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Group","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib99","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.03.060_bib100","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib101","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.03.060_bib103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/M18-2808","article-title":"Predicting bleeding risk to guide aspirin use for the primary prevention of cardiovascular disease: a cohort study","volume":"170","author":"Selak","year":"2019","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib104","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2018.07.044","article-title":"Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients","volume":"269","author":"Marzona","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191592","article-title":"Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation","volume":"13","author":"Bassand","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2020.03.060_bib106","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2020.03.060_bib107","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: Should we use a CHAD2DS2-VA score rather than CHAD2DS2-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euy067","article-title":"Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society","volume":"20","author":"Linde","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2020.03.060_bib109","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.amjcard.2012.08.014","article-title":"Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM)","volume":"110","author":"Sullivan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2013.10.035","article-title":"Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants","volume":"113","author":"Pancholy","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib111","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjcard.2016.09.049","article-title":"Gender-specific differences for risk of disability and death in atrial fibrillation-related stroke","volume":"119","author":"Martin","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib112","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/jwh.2016.5892","article-title":"Indirect comparison of novel oral anticoagulants in women with nonvalvular atrial fibrillation","volume":"26","author":"Moseley","year":"2017","journal-title":"J\u00a0Women's Health"},{"key":"10.1016\/j.jacc.2020.03.060_bib113","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Euro Heart J"},{"key":"10.1016\/j.jacc.2020.03.060_bib114","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2020.03.060_bib115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.AOG.0000431053.33593.2d","article-title":"ACOG Committee Opinion No. 565: hormone therapy and heart disease","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.03.060_bib116","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.03.060_bib117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.03.060_bib118","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.03.060_bib119","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial","volume":"161","author":"Harman","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib121","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.03.060_bib122","first-page":"CD004143","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"1","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2020.03.060_bib123","series-title":"Braunwald's Heart Disease\u2013A Textbook of Cardiovascular Medicine","first-page":"1879","article-title":"Psychiatric and behavioral aspects of cardiovascular disease","author":"Vaccarino","year":"2019"},{"key":"10.1016\/j.jacc.2020.03.060_bib124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrcardio.2017.189","article-title":"Effects of stress on the development and progression of cardiovascular disease","volume":"15","author":"Kivimaki","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neubiorev.2016.04.023","article-title":"Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women","volume":"74","author":"Vaccarino","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jacc.2020.03.060_bib127","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrcardio.2016.181","article-title":"Depression and coronary heart disease","volume":"14","author":"Carney","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jad.2016.02.029","article-title":"Depression is a risk factor for incident coronary heart disease in women: an 18-year longitudinal study","volume":"196","author":"O'Neil","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jacc.2020.03.060_bib129","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jacc.2008.10.060","article-title":"Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study","volume":"53","author":"Whang","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.annepidem.2012.06.102","article-title":"Depressed mood and cause-specific mortality: a 40-year general community assessment","volume":"22","author":"Wyman","year":"2012","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/aje\/kwv149","article-title":"Depressive symptoms during adolescence and young adulthood and the development of type 2 diabetes mellitus","volume":"183","author":"Suglia","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib132","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/CIR.0000000000000536","article-title":"Childhood and adolescent adversity and cardiometabolic outcomes: a scientific statement from the American Heart Association","volume":"137","author":"Suglia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.03.060_bib133","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/hrt.2009.188250","article-title":"Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease","volume":"96","author":"Korkeila","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.03.060_bib134","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jacc.2010.03.034","article-title":"Anxiety and risk of incident coronary heart disease: a meta-analysis","volume":"56","author":"Roest","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.03.060_bib135","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S2215-0366(16)30377-7","article-title":"Post-traumatic stress disorder and cardiovascular disease","volume":"4","author":"Edmondson","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jacc.2020.03.060_bib136","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R)","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jacc.2020.03.060_bib137","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1037\/0278-6133.28.1.125","article-title":"A\u00a0prospective study of posttraumatic stress disorder symptoms and coronary heart disease in women","volume":"28","author":"Kubzansky","year":"2009","journal-title":"Health Psychol"},{"key":"10.1016\/j.jacc.2020.03.060_bib138","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.114.014492","article-title":"Trauma exposure and posttraumatic stress disorder symptoms predict onset of cardiovascular events in women","volume":"132","author":"Sumner","year":"2015","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720347537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720347537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:33:46Z","timestamp":1760016826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720347537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":137,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0735109720347537"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.03.060","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.03.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}